Aging and Comorbidities in Acute Pancreatitis I: A Meta-Analysis and Systematic Review Based on 194,702 Patients

Katalin Márta1,2, Alina-Marilena Lazarescu1,3, Nelli Farkas1,4

  • 1Institute for Translational Medicine, University of Pécs Medical School, Pécs, Hungary.

Insights

Aging significantly increases the risk and mortality of acute pancreatitis (AP). Severe AP incidence and death rates rise linearly with age, with a sharp increase after 59, highlighting the impact of aging on AP outcomes.

Area of Science:

  • Gastroenterology
  • Geriatrics
  • Epidemiology

Background:

  • Acute pancreatitis (AP) is a leading cause of gastrointestinal hospitalization globally.
  • While often mild, 10-20% of AP cases result in severe disease with increased mortality.
  • Age is a recognized risk factor in established AP severity scoring systems.

Approach:

  • A systematic literature search was performed across Embase, Cochrane, and PubMed.
  • Meta-analysis included 33 publications with 194,702 AP patients, analyzed across seven age categories.
  • Statistical methods included meta-regression and publication bias tests; quality was assessed using the modified Newcastle-Ottawa scale.

Key Points:

  • Severe AP incidence increased linearly from 1.6% in those under 30 to 9.6% by age 70.
  • Mortality rates showed a continuous rise until age 59, then increased ninefold by age 70.
  • Patients over 70 had a 19-fold higher mortality risk compared to those under 20.

Conclusions:

  • Advanced age is strongly associated with increased likelihood of severe acute pancreatitis and higher pancreatitis-related mortality.
  • A critical inflection point for mortality elevation appears around age 59, suggesting the exacerbating role of comorbidities in older individuals.

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
125
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
129
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
601
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
588
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
208
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
1.0K